Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sul Long

Amphastar Pharmaceuticals, Inc.NASDAQ

Beschreibung

⋅ 3. Mai 2021 19:35

AMPH: Amphastar Pharmaceuticals, Inc.
2021-05-03 06:00:00
Amphastar Pharmaceuticals Receives FDA Approval for Morphine Sulfate Injection